Squeeze-out set to complete Santen's acquisition of Novagali
This article was originally published in Scrip
Executive Summary
Santen Pharmaceutical is to launch a squeeze-out for the remaining shares in Novagali Pharma it did not acquire under a simplified cash tender offer for the French firm earlier this month, which took its holding to 96.73% of the share capital and voting rights.